[email protected]
Ari Johnson
Founder and CEO, Muso; Associate Professor of Medicine at University of California San Francisco Institute for Global Health Sciences
Ari Johnson is co-founder and CEO of Muso, a global health organization working to stop preventable deaths in the world’s poorest communities. He is an associate professor of medicine at University of California San Francisco Institute for Global Health Sciences and treats patients at San Francisco General Hospital.
Johnson has published peer-reviewed articles and essays in the fields of infectious disease, health systems design, socioeconomic determinants of health, AIDS, and migration. For his work at Muso, he is the co-recipient of the 2021 Charles Bronfman Prize, an annual award presented to a humanitarian under 50 whose innovative work, informed by Jewish values, has significantly improved the world.
Over the past fifteen years, Johnson has supported Muso to pursue a cure for delayed health care, one of the world's leading causes of death and inequity. Johnson supported Muso to design and build Proactive Community Case Management, a strategy for rapid, universal access to care. A recent study in BMJ Global Health documented how communities served by this proactive strategy have achieved and sustained a rate of child death lower than any country in Sub-Saharan Africa for five years running. Muso currently cares for 330,000 patients, and supports the governments of Mali and Côte d’Ivoire to redesign their national health systems to pursue universal, early access to care.
Related Speakers View all
Thomas Priselac
President & CEO of Cedars-Sinai Health System
|
|
Marcella Nunez-Smith
Chair of the COVID-19 Health Equity Task Force; Asso...
|
|
Karen DeSalvo
Chief Health Officer at Google, Former Assistant Sec...
|
|
Taren Grom
Co-Founding Partner at PharmaLinx & Editor of Pharma...
|
|
Ashish K. Jha, MD, MPH.
Dean of Brown University School of Public Health
|
|
David Williams
Professor of Public Health at Harvard University
|
|
Laurie Zephyrin
Vice President for Advancing Health Equity at The Co...
|
|
Judy Monroe
President & CEO of the CDC Foundation
|
|
Kim Keck
President & CEO of the BlueCross BlueShield Association
|
|
Arpa Garay
President of Global Pharmaceuticals, Commercial Anal...
|
|
Brendan Carr
Mount Sinai Professor and Chair of Emergency Medicin...
|
|
Dr. Joel Selanikio
Award-Winning Physician, Health & Technology Activis...
|
|
Ruth Katz
Vice President & Executive Director of Aspen Institu...
|
|
Kevin Schulman
Professor Of Medicine at the Clinical Excellence Res...
|
|
Andrea Wainer
Executive Vice President of Rapid and Molecular Diag...
|
|
Adolfo García-Sastre
Director of Global Health and Emerging Pathogens Ins...
|
|
Morris Birnbaum
Senior Vice President and Chief Scientific Officer o...
|
|
Serena Auñón-Chancellor
NASA Astronaut, Associate Professor of Clinical Medi...
|
|
Emmanuel Agogo
Nigeria Country Representative at Resolve to Save Li...
|
|
Kenneth L. Davis
President & CEO of Mount Sinai Health System; Leadin...
|